On-skin printing of sensors could monitor COVID-19 symptomsScientists say on-skin printing could be used to create on-body sensors to monitor physiological signals and devices to Share XOn-skin printing of sensors could monitor COVID-19 symptomshttps://pharmaphorum.com/news/on-skin-printing-of-sensors-could-monitor-covid-19-symptoms/
Boehringer, Yale trial digital tech in heart failurePatients with heart failure often have a dismal prognosis as the condition usually worsens over time, but a Share XBoehringer, Yale trial digital tech in heart failurehttps://pharmaphorum.com/news/boehringer-yale-trial-digital-tech-in-heart-failure/
Astellas doubles down on partnership and buys bioelectronics firm iotaAstellas Pharma is to buy bioelectronic medical devices firm iota Biosciences in a deal worth up to $429m, Share XAstellas doubles down on partnership and buys bioelectronics firm iotahttps://pharmaphorum.com/news/astellas-doubles-down-on-partnership-and-buys-bioelectronics-firm-iota/
Blue Oak taps AI specialist Exscientia for CNS drug discoveryUS startup Blue Oak Pharma has joined a lengthening list of companies turning to Exscientia of the UK Share XBlue Oak taps AI specialist Exscientia for CNS drug discoveryhttps://pharmaphorum.com/news/blue-oak-taps-ai-specialist-exscientia-for-cns-drug-discovery/
Record number of health firms feature in UK top 100 private tech listA record number of health and medtech companies have been included in the Sunday Times Sage Tech Track Share XRecord number of health firms feature in UK top 100 private tech listhttps://pharmaphorum.com/news/babylon-among/
UK’s COVID-19 app has sent one venue alert, despite reports of rising infection ratesIt was supposed to be at the heart of the UK government’s fight against coronavirus – but after Share XUK’s COVID-19 app has sent one venue alert, despite reports of rising infection rateshttps://pharmaphorum.com/news/uks-covid-19-app-has-sent-one-venue-alert-despite-government-plans-to-close-pubs-in-england/
NHS digital triage provider to expand with £5m investmentEquity investor Gresham House has invested £5m into the NHS’s digital triage provider eConsult Health, allowing the service Share XNHS digital triage provider to expand with £5m investmenthttps://pharmaphorum.com/news/nhs-digital-triage-provider-to-expand-with-5m-investment/
RHYTHM AI cleared for large trial of atrial fibrillation mapping toolUK-based RHYTHM AI is to go ahead with a larger clinical trial of its artificial intelligence (AI)-driven system, Share XRHYTHM AI cleared for large trial of atrial fibrillation mapping toolhttps://pharmaphorum.com/news/rhythm-ai-cleared-for-large-trial-of-atrial-fibrillation-mapping-tool/
Toppan and FIGUR8 press on with remote physical training guidance pilotJapan’s Toppan Printing and MIT spin-off FIGUR8 have announced results of a pilot scheme testing a remote physical Share XToppan and FIGUR8 press on with remote physical training guidance pilothttps://pharmaphorum.com/news/toppan-and-figur8-press-on-with-remote-physical-training-guidance-pilot/
